Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629052 · ClinicalTrials.gov registry record
TrEatment Approach in the Multimodal Era Registry
A clinical trial of Chronic Thromboembolic Pulmonary Hypertension and CTEPH, sponsored by International CTEPH Association.
- Active
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT05629052: Active study of Chronic Thromboembolic Pulmonary Hypertension and CTEPH, sponsored by International CTEPH Association.
NCT05629052 is a study of Chronic Thromboembolic Pulmonary Hypertension and CTEPH that is active but no longer recruiting, run by International CTEPH Association. The registered enrollment target is 1,000 participants, above the 617-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (62% higher). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05629052, a study of Chronic Thromboembolic Pulmonary Hypertension and CTEPH, is active but no longer recruiting, sponsored by International CTEPH Association.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this observational patient registry is to learn how expert centers treat patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition in which blood clots block the blood vessels in the lungs. There are currently three treatment options for patients with CTEPH: * surgery to remove blood clots from large vessels in the lungs (pulmonary endarterectomy (PEA)) * the use of a small balloon to unblock smaller blood vessels (balloon pulmonary angioplasty (BPA)) * drugs Patients can also receive a combination of these treatments. The main question this registry aims to answer are: * How many patients receive a given kind of treatment? * How do expert centers combine the different treatments? * Are patients doing better after they receive a given kind of treatment? * How many patients are alive 1, 3 and 5 years after they receive a given kind of treatment? Participants will receive the same treatments that they would receive if they did not participate in the study. During the study, patients will visit their doctors as they would do normally. The doctors will collect information on the patients' health and enter it into the study database. The follow-up time will be at least 3 years for all patients.
Primary Outcome
Proportion of patients undergoing a certain type of treatment modality, or a certain combination of modalities
Conditions Studied
Interventions
- PROCEDURE Pulmonary endarterectomy
- PROCEDURE Balloon pulmonary angioplasty
- DRUG Pulmonary hypertension (PH)-specific medication
Study Locations (20)
Other
- Hospital Universitario Fundación Favaloro - Buenos Aires
- University Hospital Vienna - Vienna
- University Hospitals Leuven - Leuven
- Santa Casa - Porto Alegre
- China-Japan Friendship Hospital - Beijing
- Shaio Clinic Foundation - Bogotá
- General University Hospital - Prague
- Aarhus University Hospital - Aarhus
- Kerckhoff Clinic, Department of Thoracic Surgery - Bad Nauheim
- Narayana Institute of Cardiac Science - Bangalore
- University of Bologna - Bologna
- Okayama Medical Center - Okayama
- National Cerebral and Cardiovascular Center - Osaka
- National Heart Institute - Mexico City
- Department of Cardiac and Vascular Diseases, John Paul II Hospital - Krakow
California
- University of California San Diego - San Diego
Illinois
- Northwestern University - Evanston
North Carolina
- Duke University - Durham
Texas
- UT Southwestern - Dallas
Ontario
- Toronto General Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2028-04 |
What the registry record for NCT05629052 still lists
NCT05629052 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 617-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (62% higher).
The record links to 2 conditions, with Chronic Thromboembolic Pulmonary Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Pulmonary endarterectomy is the first listed.
NCT05629052 names 20 study sites across 6 states, led by Other, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT05629052 about?
NCT05629052 is a clinical study titled "TrEatment Approach in the Multimodal Era Registry". The goal of this observational patient registry is to learn how expert centers treat patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition in which blood clots block the blood vessels in the lungs. There are currently three treatment options for patients with CTEP...
What is the current status of trial NCT05629052?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2023-04-12. Estimated completion is 2028-04.
What conditions does trial NCT05629052 study?
This clinical trial studies the following conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH.
What interventions are being tested in trial NCT05629052?
The interventions under investigation include: Pulmonary endarterectomy (PROCEDURE), Balloon pulmonary angioplasty (PROCEDURE), Pulmonary hypertension (PH)-specific medication (DRUG).
Who is sponsoring clinical trial NCT05629052?
This trial is sponsored by International CTEPH Association, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05629052 being conducted?
This trial has 20 study locations across California, Illinois, North Carolina, Texas, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Thromboembolic Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Pulmonary Hypertension Biorepository and Registry
RECRUITING
-
Chronic Thromboembolic Disease Registry
RECRUITING
-
Pulmonary Hypertension Association Registry
RECRUITING
-
Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI